Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Thomas R. Vrobel"'
Autor:
John P. Kirwan, Hussein N. Yassine, Frank González, Raj K. Krishnan, Thomas R. Vrobel, Christine M. Marchetti
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. :90-95
Background. The prevalence of insulin resistance, metabolic syndrome, and cardiovascular disease is greatest in older obese patients, and effective evidence-based treatment strategies are lacking. Methods. A prospective controlled study was conducted
Autor:
Thomas B. Ivanc, Stephen G. Ellis, John Strony, Sorin J. Brener, Eric J. Topol, A. A. Jennifer Adgey, E. Magnus Ohman, Karl-Ludwig Neuhaus, Uwe Zeymer, Nadine Juran, Michael M. Kitt, Thomas R. Vrobel
Publikováno v:
Journal of the American College of Cardiology. 39(3):377-386
Objectives This study was designed to test the hypothesis that eptifibatide and reduced-dose tissue plasminogen activator (t-PA) will enhance infarct artery patency at 60 min in patients with acute myocardial infarction (AMI). Background Combination
Publikováno v:
American Heart Journal. 120:1356-1363
To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol. In 18 of 19 p
Autor:
Sorin J, Brener, Uwe, Zeymer, A A Jennifer, Adgey, Thomas R, Vrobel, Stephen G, Ellis, Karl Ludwig, Neuhaus, Nadine, Juran, Thomas B, Ivanc, E Magnus, Ohman, John, Strony, Michael, Kitt, Eric J, Topol
Publikováno v:
Journal of the American College of Cardiology. 39(3)
This study was designed to test the hypothesis that eptifibatide and reduced-dose tissue plasminogen activator (t-PA) will enhance infarct artery patency at 60 min in patients with acute myocardial infarction (AMI).Combination fibrin and platelet lys
Publikováno v:
Journal of the American College of Cardiology. 41:30
Publikováno v:
Progress in Cardiovascular Diseases. 31:393-426
Although amiodarone is a highly effective antiarrhythmic agent, it has a high incidence of side effects, some of which can be serious or even lethal. With close monitoring, side effects can be found in essentially all patients, but fortunately most o
Publikováno v:
Journal of the American College of Cardiology. 2(5):926-933
To determine the relation of heart rate and systolic function to echocardiographically derived indexes of left ventricular relaxation, M-mode echocardiograms of the left ventricle and mitral valve with a simultaneous phono-cardiogram were recorded at
Autor:
Robert S. Finkelhor, Thomas R. Vrobel, Kenneth E. Newhouse, Robert C. Bahler, Stefan D. Miron
Publikováno v:
American Heart Journal. 112:296-304
The ST segment shift relative to exercise-induced increments in heart rate, the ST/heart rate slope (ST/HR slope), has been proposed as a more accurate ECG criterion for diagnosing significant coronary artery disease (CAD). Its clinical utility, with
Publikováno v:
American heart journal. 111(1)
Publikováno v:
Journal of the American College of Cardiology. 4(1)
A major disadvantage of conventional amiodarone therapy is the long delay between initiation of therapy and arrhythmia suppression. In this study, the hypothesis was tested that complex ventricular arrhythmias would be suppressed rapidly by an intrav